Cancer & Clinical proteomics

Clinical Proteomic Tumor Analysis Consortium (CPTAC), is to link cancer genome to proteome by systematically analyzing the protein content of tumors of which there is comprehensive genomic characterization from initiatives such as The Cancer Genome Atlas. This integrative approach will produce a deeper understanding of cancer biology, with high-quality datasets, reagents, and analytically validated quantitative assays to be made publicly available.

 

  • Cancer biomarker development
  • Clinical applications of proteomics
  • Proteomics in cell biology and disease mechanisms
  • Protein biomarker discovery and delivery
  • Renal and urinary proteomics
  • Proteomics of microbial pathogens
  • Proteomics for mechanistic insight into cancer
  • Proteomics in development of anti-cancer therapeutics

Related Conference of Cancer & Clinical proteomics

June 26-28, 2017

3rd Glycobiology World Congress

London, UK
August 21-22,2017

Global Proteomics Conference

Kuala lumpur, Malaysia
September 18-20, 2017

9th International Conference on Structural Biology

Zurich, Switzerland
September 21-22, 2017

International Conference on Glycobiology

Houston, Texas, USA
September 28-29, 2017

2nd International Conference on Biochemistry

Dubai, UAE
October 30 - November 01, 2017

3rd International Conference on Transcriptomics

Bangkok, Thailand
November 13-15, 2017

9th International Conference and Expo on Proteomics

Paris, France
November 13-14, 2017

9th International Conference on Bioinformatics

Paris, France
December 07-09, 2017

Biochemistry- 2017 (CME & CPD Accredited)

Frankfurt, Germany

Cancer & Clinical proteomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in